Omicron can evade protection offered by Covid vaccines, antibody therapies: Study

Omicron can evade protection offered by Covid vaccines, antibody therapies: Study

The study, published in the journal Nature on Thursday, also highlights the need for new vaccines and treatments that anticipate how the SARS-CoV-2 virus may soon evolve. Omicron can evade the immune protection conferred by COVID-19 vaccines and natural infection, according to a peer-reviewed study which also suggests that the new variant of coronavirus is … Read more

Two-dose vaccines induce lower antibodies against Omicron, study finds

Two-dose vaccines induce lower antibodies against Omicron, study finds

Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely. Researchers from the University of Oxford published results on Monday from a study yet to be peer-reviewed, where they analysed blood samples from participants … Read more

Indonesia to start vaccinating children aged 6-11 against COVID-19

Indonesia to start vaccinating children aged 6-11 against COVID-19

Indonesia will start administering COVID-19 vaccinations for children aged between 6-11 on Tuesday, a health ministry official said, as the Southeast Asian country becomes one of the first in the region to immunise the very young. Indonesia approved China’s Sinovac Biotech vaccine for the age group last month and about 26.5 million children have been … Read more

AstraZeneca CEO on long-term protection from jab

AstraZeneca CEO on long-term protection from jab

The boss of pharmaceutical giant AstraZeneca says its coronavirus vaccine – developed with Oxford University – may have played a key role in reducing Covid-related hospitalisations in the UK. Pascal Soriot said his company’s vaccine promoted a greater T-cell [part of the immune system which defends the body against specific infections] response in older people … Read more

Serum-produced Covishield crosses 100-cr jab mark in India

Serum-produced Covishield crosses 100-cr jab mark in India

SII estimates that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Serum Institute of India’s Covid-19 vaccine Covishield on Tuesday crossed the 100-crore vaccination mark. The country has administered 113.55 crore Covid-19 vaccines till date, and of these, 100.31 crore were Covishield. Two billion doses of … Read more

Now, ‘international vaccine certificates’ made available on CoWin following UK complaint

Now, ‘international vaccine certificates’ made available on CoWin following UK complaint

The update includes mainly displaying the vaccinated person’s birth date on the certificate. (File) The National Health Authority (NHA) has made vaccine certificates compliant with the World Health Organization’s (WHO) specifications, detailed in its Digital Documentation of Covid-19 Certificates: Vaccination Status. The move comes after British authorities raised doubts over the format of India’s vaccination … Read more

Covid-19: How UK’s new travel rules affect flyers from India

Covid-19: How UK’s new travel rules affect flyers from India

From October 4, the UK will have only one list of countries — red. (File) The UK’s updated Covid-19 travel rules place Indians inoculated with Covishield in the ‘unvaccinated’ category. While the country has relaxed the regulations for those with two doses of the Oxford-AstraZeneca jab, the same version being manufactured in India Serum Institute … Read more